Oligomerization of nod-like receptors (NLRs) can be detected by several biochemical techniques dependent on the stringency of protein-protein interactions. Some of these biochemical methods can be combined with functional assays, such as caspase-1 activity assay. Size exclusion chromatography (SEC) allows separation of native protein lysates into different sized complexes by fast protein liquid chromatography (FPLC) for follow-up analysis. Using co-immunoprecipitation (co-IP), combined with SEC or on its own, enables subsequent antibody-based purifi cation of NLR complexes and associated proteins, which can then be analyzed by immunoblot and/or subjected to functional caspase-1 activity assay. Chemical crosslinking covalently joins two or more molecules, thus capturing the oligomeric state with high sensitivity and stability. Apoptosis-associated speck-like protein containing a caspase activation domain (ASC) oligomerization has been successfully used as readout for NLR or AIM2-like receptor (ALR) infl ammasome activation in response to various pathogen-or damage-associated molecular patterns (PAMPs or DAMPs) in human and mouse macrophages and THP-1 cells. Here, we provide a detailed description of the methods used for NLRP7 oligomerization in response to infection with Staphylococcus aureus ( S. aureus ) in primary human macrophages, co-immunoprecipitation and immunoblot analysis of NLRP7 and NLRP3 infl ammasome complexes, as well as caspase-1 activity assays. Also, ASC oligomerization is shown in response to dsDNA, LPS/ATP, and LPS/nigericin in mouse bone marrow-derived macrophages (BMDMs) and/or THP-1 cells or human primary macrophages.
Introduction
Nod-like receptors (NLRs) ass emble into large oligomeric signaling complexes, such as infl ammasomes and nodosomes [ 1 , 2 ] . Several biochemical methods, which are based on the detection of protein-protein interactions, are established to detect and quantify the conversion of monomeric proteins into active oligomeric protein complexes [ 3 -5 ] . Size exclusion chromatography (SEC) is based on the separation of native protein complexes according to their size by migration through a gel matrix, which consists of spherical beads containing pores of a specifi c size distribution [ 6 ] . When molecules of different sizes are included or excluded within the matrix, it results in separation of these molecules depending on their overall sizes. Small molecules diffuse into pores and are retarded depending on their size, whereas large molecules, which do not enter the pores, are eluted with the void volume of the column. As the molecules pass through the column, they are separated on the basis of their size and are eluted in the order of decreasing molecular weights. Here we describe SEC of the oligomerized NLRP7 complex in response to S. aureus infection of human primary macrophages [ 7 ] .
Immunoprecipitation ( IP ) and co-immunoprecipitation (co-IP) are routinely used techniques to study protein-protein interactions and to identify novel members of protein complexes [ 3 , 8 , 9 ] . Both techniques use an immobilized antibody specifi c to the antigen/protein of interest. While IP is designed to purify a single antigen, co-IP is suited to isolate the specifi c antigen/protein as well as to co-purify any other associated proteins, which are then separated by SDS/PAGE and detected by immunoblotting. Interacting proteins might include complex partners, cofactors, signaling molecules, etc. The strength of the interaction between proteins may range from highly transient to very stable interactions. While studying these interactions by co-IP, there are a number of factors which should be taken under consideration, e.g., specifi city of the antibody, optimization of the binding and wash conditions, posttranslational modifi cations, etc. Here, we describe a co-IP protocol for the endogenous ASC-NLRP3 complex from THP-1 cells and BMDMs and the ASC-NLRP7 complex from human primary macrophages, as the recruitment of ASC to these NLRs is a readout for infl ammasome assembly. A particularly useful approach is the combination of SEC with co-IP to allow the analysis of complexes within a specifi c size fraction, for example, for analyzing NLR-containing complexes within high molecular weight fractions.
This analysis furthe r enables the detection of caspase-1 within infl ammasomes and allows quantifi cation of its activity, when combined with caspase-1 activity assays. Caspase-1, also known as interleukin (IL)-1β-converting enzyme (ICE), is a cysteine protease and is the downstream effector molecule that becomes activated within infl ammasomes subsequent to the activation of several NLRs [ 10 ] . The active 20 kDa and 10 kDa hetero-tetrameric caspase-1 is derived from the auto-proteolytically cleaved 45 kDa proenzyme (zymogen) [ 11 , 12 ] . Subsequently, the caspase-1 substrate pro-IL-1β (35 kDa) is converted into the biologically active form (17 kDa) [ 13 -15 ] . Here we describe two assays that determine caspase-1 activity, which are routinely used in our laboratory [ 7 ] . First, a sensitive fl uorometric assay that quantifi es caspase-1 activity within the NLRP7 infl ammasome, where the preferential recognition of the tetrapetide sequence YVAD by caspase-1 is utilized in combination with the detection of the fl uorescent substrate 7-amino-4-trifl uoromethyl coumarin (AFC) [ 16 ] . YVAD-AFC e mits blue light (400 nm), but once the substrate is cleaved by caspase-1, the free AFC emits yellow-green fl uorescence (505 nm), which can be quantifi ed in a plate reader with fl uorescence capabilities and the appropriate fi lter sets. Second, the caspase-1 substrate pro-IL-1β is converted into mature IL-1β, which can be detected by Western blot analysis [ 7 ] .
Chemical cross-linking covalently joins two or more molecules [ 17 ] . Cross-linking reagents (or cross-linkers) consist of two or more reactive ends. This enables cross-linkers to chemically attach to specifi c functional groups (e.g., sulfhydryls, primary amines, carboxyls, etc.) on proteins or other molecules. Cross-linkermediated attachment between groups on two different protein molecules leads to intermolecular cross-linking. This cross-linking results in the stabilization of protein-protein interactions. Crosslinkers can be selected on the basis of their chemical reactivity and properties, like chemical specifi city, water solubility, membrane permeability, etc. [ 17 ] . Here, we describ e the cross-linking of nucleated and polymerized ASC molecules using the membranepermeable, nonreversible cross-linker disuccinimidyl suberate (DSS), which contains an amine-reactive N-hydroxysuccinimide (NHS) ester at each end of an 8-carbon spacer arm ( see Note 1 ). ASC oligomerization has been successfully used as a readout for NLR or ALR infl ammasome activation in response to various PAMPs and DAMPs in primary macrophages as well as monocytes [ 18 , 19 ] . We describe ASC oligomerization in response to poly(dA:dT) (dsDNA) as well as LPS/ATP or LPS/nigericin in mouse BMDM and THP-1 cells [ 20 ] .
Materials
All solutions shou ld be prepared using ultrapure water (sensitivity of 18 MΩ·cm at 25 °C) and analytical grade reagents. 3. Phosph ate-buffered saline (PBS) solution.
4. 100/60 mm tissue culture dishes.
5. 1.5 and 2 ml microcentrifuge tubes.
Cell Culture and Antibodies
6. 15 ml centrifuge tubes.
7. Cell scrappers.
8. Refrigerated tabletop centrifuge with 1.5 ml microcentrifuge tube rotor.
9. Tabletop centrif uge with 15 ml tube rotor.
10. Heat block.
11. 10× protease inhibitor cocktail (we use the cocktail from Roche, but other cocktails could be also used).
12. 0.1 M phenylmethylsulfonyl fl uoride (PMSF) in ethanol.
13. Poly(dA:dT).
14. Ultrapure E. coli lipopolysaccharide (LPS), serotype 0111:B4.
15. ATP.
16. Ni gericin.
17. Laemmli sample loading buffer: 60 mM Tris-HCl, pH 6.8, 2 % sodium dodecyl sulfate (SDS), 100 mM dithiothreitol (DTT), 10 % glycerol, and 0.01 % bromophenol blue.
18. SDS/PAGE and blotting equipment and materials.
19. Anti-ASC antibody (we use Santa Cruz, sc-22514-R).
20. Anti-NLRP3 antibody (we use Adipogen, Cryo-2, AG-20B-0014).
21. Anti-NLRP7 anti body (we use Imgenex, IMG-6357A).
1. Fast protein liquid chromatography (FPLC) equipment (we use a Bio-Rad BioLogic LP Chromatography System, but other systems are also suitable).
G el fi ltration column. We use GE Healthcare HiPrep 16/60
Sephacryl S-300 High-Resolution Column (matrix, 50 μm allyl dextran and N , N ′-methylenebisacrylamide; bed dimension, 16 × 600 mm; bed volume, 120 ml). Other similar columns are also suitable.
3. System tubing of 1.6 mm internal diameter.
4. Fraction collector.
5. 5 ml round bottom tubes.
6. Separ ation buffer: 50 mM Tris, pH 7.4, 150 mM NaCl.
7. Lysis buffer: 10 mM Na 4 P 2 O 7 , 10 mM NaF, 20 mM Tris, pH 7.4, 150 mM NaCl, 1 % octylglucoside, 1 mM PMSF, and 1× protease inhibitor cocktail.
Trichloroacetic acid (TCA).
9. Acetone.
10. 20 % ethanol.
11. Gel fi ltrati on standard (we use Bio-Rad 151-1901).
Size Exclusion Chromatography (SEC)
12. Dounce homogenizer.
13. Sonicator.
14. 3 ml syringe using an 18½-gauge needle.
15. 0.45 μM syringe fi lter.
1. IP lysis buff er: 50 mM HEPES, pH 7.4, 150 mM NaCl, 10 % glycerol, 2 mM EDTA, 0.5 % Triton X-100, 1× protease inhibitor cocktail.
2. Specifi c antibody against NLR of interest ( see Subheading 2.1 ).
3. Protein A/G-Sepharose (we use the Protein A/G-Sepharose ® 4B from Life Technologies).
1. 10 m M Ac-YVAD-AFC. This is a stock solution and should be prepared in dimethyl sulfoxide (DMSO); protect solution from light.
2. Caspase-1 lysis buffer: 150 mM NaCl, 20 mM Tris, pH 7.5, 0.2 % Triton X-100; add freshly : 1 mM DTT.
3. Caspase assay buffer: 50 mM HEPES, 7.2-7.4, 50 mM NaCl, 1 mM EDTA, 0.1 % CHAPS, 10 % sucrose; add freshly : 10 mM DTT, 100 μM substrate Ac-YVAD-AFC.
1. pro-IL-1β cDNA.
2. Anti-IL-1β antibody suitable for Western blotting (e.g., we use cell signaling antibody clone 3A6, 12242).
1. 100 mM disucc inimidyl suberate (DSS). This is a stock solution and should be prepared in DMSO ( prepare freshly just before adding to the lysates ).
2. Lysis buffer: 20 mM HEPES-KOH, pH 7.5, 150 mM KCL, 1 % NP-40, 0.1 mM PMSF, 1× of protease inhibitor cocktail, 1 mM sodium orthovanadate (PMSF should be added to the lysis buffer just before cell lysis). [ 7 , 20 ] . Extracellular bacteria will be eliminated with gentamicin (50 mg/ml) for a total time of 90 min [ 7 ] ( see Note 3 ).
Methods
1. Connect the co lumn according to the manufacturer's instructions and verify proper bubble-free packing of the column.
2. Equilibrate the column with ½ column volume (CV) ddH 2 O (60 ml) at a fl ow rate of 0.5 ml/min, followed by 2 CV (240 ml) separation buffer at 1 ml/min at 4 °C. 6. Prior to homogenization, prechill a glass of 2 ml Dounce tissue grinder on ice, transfer lysate to the cooled tissue grinder, and homogenize through 30 strong strokes, carefully avoiding bubble formation.
7. Following homogenization, place the lysate in a 2 ml microcentrifuge tube and spin at 12,000 × g for 30 min to clarify the lysate.
8. Transfer the cleared lysates to a fresh tube and then draw it into a 3 ml syringe using an 18½-gauge needle. Perform a second clarifi cation step to remove any remaining debris us ing a 0.45 μM syringe fi lter. Draw the fi nal lysate in a new 3 ml syringe for injection into the chromatography system or store it at 4 °C until injection.
9. Carefully examine the lysate within the syringe for any air bubbles prior to injection, and if necessary remove it by gently fl icking the syringe.
10. Insert the syringe into the injection valve in the valve controller and inject the lysate into a sample loop, which needs to fi t the entire lysate (we usually use a 2.5 ml sample loop) prior to introducing it into the separation column. During injection, the fl o w of the chromatography system bypasses the sample loop. Adjust the fl ow rate to 0.5 ml/min, and use the valve selection device to divert the fl ow into the sample loop, which is subsequently connected to the separation column and the rest of the system. Take care to avoid any introduction of air bubbles into the system.
11
. Start an automated collection program:
Size Exclusion Chromatography (SEC)
(a) 0.5 ml/min fl ow rate for 72 min, diverting fl ow to disposal (column dead volume).
(b) 0.5 ml/min fl ow rate for 216 min, diverting fl ow to fraction collector; collect 9 min/fraction (4.5 ml) for a total of 24 fractions.
(c) Divert fl ow to waste for another 200 min at 0.5 ml/min to remove any small molecules remaining in the column.
12. Continuously monitor fractions by UV absorbance.
13. Initiate any subsequent injections at this point, repeating steps 10 -12 .
14. At this step, eith er continue with co-IP ( see Subheading 3.3 below) or continue for TCA precipitation and Western blot analysis.
15. Divide each fraction into three 1.5 ml aliquots in 2 ml microcentrifuge tubes.
16. TCA precipitates proteins by adding 500 μl 100 % w/v trichloroacetic acid per tube. Mix tubes and incubate on ice for at least 10 min and collect proteins by centri fugation at 14,000 × g for 30 min. White protein precipitates are present at the bottom of the tubes. Discard the supernatants and wash pellets with 0.5 ml of ice-cold acetone with vortexing and pool the contents of three tubes corresponding to the same fraction and spin at 14,000 × g for 10 min.
17. Aspirate the acetone supernatant and wash the pellets twice with 1 ml of ice-cold acetone as above.
18. Aspirate the acetone and keep the tubes uncapped at 30 °C in a heat block for 10 min to evaporate any remaining acetone ( see Note 5 ).
19. Resuspe nd protein pellets in 50 μl 1.5× Laemmli buffer ( see Note 6 ). Vigorously vortex the samples to fully resuspend any insoluble portion of the pellet. Sonicate samples in a water bath to ensure maximum dissolution of the protein pellet. Boil samples in a 95 °C heat block for 10 min before separating by SDS/PAGE (a 10 % acrylamide gels is usually well suited) and analysis by immunoblotting ( see Note 7 ).
20. To match fractions to a particular molecular weight, either pre-run or post-run a gel fi ltration molecular weight standard under the same conditions. The protein standards can be d etected by UV absorbance and matched to a particular fraction. We use a lyophilized protein mixture from Bio-Rad consisting of thyroglobulin, bovine γ-globulin, chicken ovalbumin, equine myoglobin, and vitamin B12 (MW range from 1350 to 670,000 Da, pI 4.5-6.9), which we dissolve in lysis buffer.
21. Regene rate the column after each run with one CV (120 ml) separation buffer (at 1 ml/min at 4 °C) and four CV (480 ml) ddH 2 O, followed by four CV (480 ml) 20 % ethanol, and store in 20 % ethanol at 4 °C in an upright position.
1. Plate 1 × 10 7 cells in a 100 mm tissue culture dish ( see Note 8 ).
2. Wash the adher ent cells (primary human macrophages and BMDM) with ice-cold PBS. Add 1 ml of ice-cold lysis buffer. Keep the plate on ice and make sure the lysis buffer is distributed evenly. In case of THP-1 cells (suspension cells), transfer the cells to a 15 ml tube and centrifuge at 400 × g for 10 min at RT. Add 1 ml of ice-cold lysis buffer and transfer the cell suspension to a 1.5 ml tube. Incubate the cells in lysis buffer for 30 min on ice.
3. Centrifuge the cell lysates at 10,000 × g for 15 min at 4 °C.
4. Transfer the cleared lysates to a fresh 1.5 ml microcentrifuge tube. Alternatively, use a particular fraction or pooled fractions from SEC as input for the co-IP (from step 14 of Subheading 3.2 ).
Preclear lysates with 1 μg control IgG and 5 μl of Protein
A/G-Sepharose beads.
6. Centrifuge the samples at 2500 × g at 4 °C for 2 min.
7. Transfer the supernatant to a fresh 1.5 ml microcentrifuge tube.
8. Add 1 μg of spe cifi c antibody to the NLR of interest or ASC to the cleared lysates and incubate at 4 °C with rotation for 1 h ( see Note 9 ).
9. Add 5 μl of Protein A/G-Sepharose beads to the lysate-antibody mix and incubate at 4 °C with rotation for at least 2 h or overnight.
10. Centrifuge the samples at 2500 × g at 4 °C for 2 min. Remove the supernatant and wash the beads three times with 1 ml lysis buffer ( see Note 10 ).
11. Extract the immunoprecipitated proteins by adding 60 μl of Laemmli sample loading buffer and incubating at 95 °C for 10 min.
12. Centrifuge the samples at 2500 × g for 2 min to pellet the Sepharose beads.
13. Run the cleared samples on the SDS/PAGE gel and detect the immunoprecipitated proteins and the potential interacting partners by immunoblotting using specifi c antibodies.
This is an alternative approach which has be en previously used to analyze ASC-NLRP3 and ASC-NLRP7 interactions [ 7 , 20 , 21 ].
1. Transfect a 100 mm tissue culture dish of HEK293 cells with myc-ASC, control GFP, GFP-NLRP3, or GFP-NLRP7, adjusted to yield comparable expression ( see Note 11 ).
Co-immunoprecipitation (co-IP)

co-IP of Overexpressing NLR Proteins with ASC
2. 36 h post-transfection, lyse the cells in IP lysis buffer.
3. Proceed for the co-IP using protein-/tag-specifi c antibody as described in Subheading 3.3 ( see Note 12 ).
1. Pellet from 1 to 5 × 10 6 cells at 400 × g for 10 min in a centrifuge at 4 °C ( see Note 13 ).
2. Wash the cells once with ice-cold PBS.
3. Add caspase lysis buffer with fresh DTT (use the same volume as the cell pellet, as a very concentrated cell lysate is required: about 50 μl), resuspend and keep on ice for 10 min.
4. Spin for 5 min in a refrigerated centrifuge at 14,000 × g and 4 °C (full speed) and transfer supernatant into a fresh, prechilled tube (lysates can be stored at −80 °C). For different time points, snap-freeze the lysates in liquid nitrogen instead of incubating it on ice.
5. Assay equal volume of extract (determined by cell number); keep some lysates to determine protein concentration for normalization of the relative fl uorescence units (RFU) (although preferably, you determine it up front). Alternatively, it can use immobilized proteins purifi ed by co-IP experiments using immobilized anti-NLRP7, s uch as from step 10 of Subheading 3.3 in combination with SEC or directly from cell lysates, as source for the caspase-1. In this case, equilibrate beads in caspase assay buffer (lacking the substrate Ac-YVAD-AFC).
6. Turn on the fl uorescent plate reader, set up the correct excitation and emission fi lters (AFC excitation, 400 nm; emission, 505 nm), and warm up the reader to 37 °C.
7. Prepare 100 μl caspase assay buffer/sample with fresh DTT and 100 μM of substrate Ac-YVAD-AFC.
8. Add same volume of adjusted lysates, including a negative control (max: 15 μl) into white or black 96-well plates.
9. Quickly add 100 μl of assay buffer to each well (if necessary remove air bubbles quick ly with a syringe needle).
10. Measure caspase-1 activity over time for 1 h at 37 °C at 400/505 nm (excitation/emission) ( see Note 14 ).
1. Transfect a 100 mm tissue culture dish of HEK293 cells with a pro-IL-1β cDNA ( see Note 15 ). 24-36 h post-transfection, lyse cells in caspase-1 lysis buffer, and centrifuge the lysates at high speed (14,000 × g ) for 10 min at 4 °C to obtain the cleared lysate ( see Note 16 ).
2. Purify the NLRP7 complex and IgG control complex as described above (Subheading 3.3 ), except maintain the bound proteins on the Sepharose beads (do not elute proteins in Laemmli buffer) and equilibrate beads in caspase-1 assay buffer. 3. Remove the culture supernatants and rinse the cells with icecold PBS. Add 1 ml of ice-cold PBS to the plate and remove the cells using a cell scraper and transfer to 1.5 ml microcentrifuge tubes.
4. Centrifuge the cells at 400 × g for 10 min and discard the supernatant.
5. Add 500 μl ice-cold l ysis buffer to the cell pellet and lyse the cells by shearing 10 times through a 21-gauge needle.
6. Reserve 50 μl of cell lysate for Western blot analysis.
7. Centrifuge the remaining lysates at 2500 × g for 10 min at 4 °C. 
Notes
1. This approach can be modifi ed with application of a reversible cross-linker, such as dithio bis(succinimidyl propionate) (DSP) or Lomant's reagent, which contains a disulfi de bond in its spacer arm, which is cleaved by reducing agents, such as Laemmli buffer. This approach allows co-IP experiments under stringent conditions of cross-linked protein complexes and 3.7 Cross-Linking detection of purifi ed proteins by immunoblot according to their monomeric molecular weight.
2. This time point is too long for purifying the complex by co-IP and SEC or to determine caspase-1 activity, but works well for cross-linking. We used vaccinia virus or MCMV infection for shorter times (90 min) to determine the AIM2-ASC complex in response to viral DNA [ 7 ] .
3. We use activation of NLRP3 by LPS/ATP and LPS/nigericin and AIM2 by poly(dA:dT) as exam ples. However, any other inflammasome activator can be used. Crude LPS can be substituted for ultra pure LPS, but it already causes some inflammasome activation. The timing can be adjusted as needed from as short as 1 h to overnight. Similarly, the concentration of ATP and nigericin can be adjusted to cause the appropriate level of activation (usually 3-5 mM ATP and 2-5 μM nigericin is sufficient). Any transfection reagent of choice can be used for poly(dA:dT) transfection. However, the concentration may need to be adjusted based on transfection efficiency and manufacturer's protocol. Poly(dA:dT) conjugated to the cationic lipid transfection rea gent LyoVec is sold by InvivoGen for direct cytosolic delivery, but we did not obtain sufficient inflammasome activation in our hands.
4. The large number of cells is required to detect low expressing NLRs, when separated into 24 fractions.
5. Do not overdry the pellets or incubate at higher temperatures, as this will cause problems when resuspending the protein pellet. Incubating at room temperature is also suffi cient, but may require longer incubation times.
6. In case the Lae mmli buffer changes color to yellow (indicating leftover TCA and insuffi cient washing), neutralize pH with a drop of 1 M Tris base.
7. You will need more gels, or a wide gel (for example the BioRad Criterion gels can run up to 26 samples).
8. Less cells can be used, but to achieve sensitivity we usually use 60 or 100 mm dishes.
9. For the NLRP3-ASC interaction, we commonly IP with an anti-ASC antibody (Santa Cruz, sc-22514-R) and detect NLRP3 with an anti-NLRP3 antibody (Adipogen, Cryo-2, AG-20B-0014). This NLRP3 antibody also works well for IP and cross-reacts with human and mouse NLRP3. We purify the NLRP7 complex with an anti-NLRP7 antibody (Imgenex, IMG-6357A).
10. This is the step to continue to the caspase-1 activity assay, rather than Western blot analysis. Alternatively, the beads can be divided for both analyses.
11. We established cells stably expressing myc-ASC (HEK293 ASC ) for this purpose and only transfect with the NLR of interest. This helps with the usually poor expression of NLRs. At minimum, adjust expression of ASC and NLRs by transfecting approximately 1/3 ASC and 2/3 NLR. The GFP fusion stabilizes expression of NLRP3 and NLRP7, but additionally we tested HA and Flag tags, which also work.
12. In the case of epitope-tagged proteins, consider pulling down with directly Sepharose-immobilized antibodies, which are widely available and used for detecting directly HRPconjugated anti-tag antibodies, as ASC runs very close to the antibody light chain band.
13. Keep cells on ice all the time to minimize activation of caspase-1, which can be activated by cell lysing at 30 °C [ 10 ] .
14. Prolonged incu bation times for several hours may be necessary for diluted lysates or low activity.
15. We use HEK293 cells for this assay, as these cells do not express endogenous caspase-1 and therefore pro-IL-1β is not cleaved and is maintained as pro-IL-1β in the lysate. Any other cell type lacking caspase-1 would be equally suited.
16. Alterna tively, a pro-IL-18 cDNA could be used, as pro-IL-18 is also cleaved by caspase-1 [ 13 -15 , 22 ] . Several other substrates are less well characterized [ 23 -25 ] . Helpful is the use of a C-terminally epitope-tagged cDNA, as the N-terminal prodomain is proteolytically removed by caspase-1.
17. The size of pro-IL-1β is 31 kDa and of mature IL-1β is 17.5 kDa. If you use IL-18, pro-IL-18 is 24 kDa and mature IL-18 is 18 kDa.
18. Conside r running a gradient SDS/PAGE to properly resolve the multiple-sized oligomers.
